Curia Buffalo R&D, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
May 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 2, 2026The maintenance fee for Glycine TRANSPORTER-1 Inhibitors, Methods of Making Them, and Uses Thereof (US 9,045,445) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof (US 10,597,401) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,501,729 | 5-HT3 Receptor Modulators, Methods of Making, and Use Thereof In force · High confidence | In force | High confidence | |
| US 8,710,047 | 5-HT3 Receptor Modulators, Methods of Making, and Use Thereof In force (reinstated) · Medium confidence | In force (reinstated) | Medium confidence | |
| US 8,124,600 | 5-HT3 Receptor Modulators, Methods of Making, and Use Thereof In force · High confidence | In force | High confidence | |
| US 9,045,445 | Glycine TRANSPORTER-1 Inhibitors, Methods of Making Them, and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,226,456 | Methods and Compositions for Preventing Opioid Abuse In force · High confidence | In force | High confidence | |
| US 10,695,342 | Methods and Compositions for Preventing Opioid Abuse In force · Medium confidence | In force | Medium confidence | |
| US 11,020,386 | Methods and Compositions for Preventing Opioid Abuse In force · Medium confidence | In force | Medium confidence | |
| US 10,597,401 | Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 8: 2 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.